Selected research
Industry Growth & Trends
Global Blood Proteomics Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Blood Proteomics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blood Proteomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Blood Proteomics Services market include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Blood Proteomics Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Blood Proteomics Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood Proteomics Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood Proteomics Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Blood Proteomics Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Blood Proteomics Services Market by Company
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
Blood Proteomics Services Segment by Type
Blood Proteomics
Blood Modification Proteomics
Olink (Targeted) Proteomics
Blood Proteomics Services Segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Blood Proteomics Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Proteomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Proteomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Proteomics Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Blood Proteomics Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Proteomics
- Blood Modification Proteomics
- Olink (Targeted) Proteomics
Applications
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
Companies covered
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Blood Proteomics Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Blood Proteomics Services Market Size by Region (2021-2032)
- 1.4.1 Global Blood Proteomics Services Market Size by Region (2021-2026)
- 1.4.2 Global Blood Proteomics Services Market Size by Region (2027-2032)
- 1.5 Key Regions Blood Proteomics Services Market Size (2021-2032)
- 1.5.1 North America Blood Proteomics Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Blood Proteomics Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Blood Proteomics Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Blood Proteomics Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Blood Proteomics Services Market Size Growth Rate (2021-2032)
2 Blood Proteomics Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Blood Proteomics
- 2.1.2 Blood Modification Proteomics
- 2.1.3 Olink (Targeted) Proteomics
- 2.2 Global Blood Proteomics Services Market Size by Type
- 2.2.1 Global Blood Proteomics Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Blood Proteomics Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Blood Proteomics Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Blood Proteomics Services Market Size by Regions
- 2.3.1 North America Blood Proteomics Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Blood Proteomics Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Blood Proteomics Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Blood Proteomics Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Blood Proteomics Services Market Size Breakdown by Type (2021-2026)
3 Blood Proteomics Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Disease Biomarker Research
- 3.1.2 Drug Development
- 3.1.3 Clinical Research
- 3.1.4 Others
- 3.2 Global Blood Proteomics Services Market Size by Application
- 3.2.1 Global Blood Proteomics Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Blood Proteomics Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Blood Proteomics Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Blood Proteomics Services Market Size by Regions
- 3.3.1 North America Blood Proteomics Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Blood Proteomics Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Blood Proteomics Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Blood Proteomics Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Blood Proteomics Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Blood Proteomics Services Industry Trends
- 4.2 Blood Proteomics Services Industry Drivers
- 4.3 Blood Proteomics Services Industry Opportunities and Challenges
- 4.4 Blood Proteomics Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Blood Proteomics Services Revenue (2021-2026)
- 5.2 Global Blood Proteomics Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Blood Proteomics Services Key Company Headquarters & Area Served
- 5.4 Global Blood Proteomics Services Company, Product Type & Application
- 5.5 Global Blood Proteomics Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Blood Proteomics Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Blood Proteomics Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Blood Proteomics Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 BostonGene
- 6.1.1 BostonGene Company Information
- 6.1.2 BostonGene Business Overview
- 6.1.3 BostonGene Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 BostonGene Blood Proteomics Services Product Portfolio
- 6.1.5 BostonGene Recent Developments
- 6.2 CellCarta
- 6.2.1 CellCarta Company Information
- 6.2.2 CellCarta Business Overview
- 6.2.3 CellCarta Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 CellCarta Blood Proteomics Services Product Portfolio
- 6.2.5 CellCarta Recent Developments
- 6.3 GENEWIZ (Azenta Life Sciences)
- 6.3.1 GENEWIZ (Azenta Life Sciences) Company Information
- 6.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 6.3.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio
- 6.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 6.4 CDI Labs
- 6.4.1 CDI Labs Company Information
- 6.4.2 CDI Labs Business Overview
- 6.4.3 CDI Labs Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CDI Labs Blood Proteomics Services Product Portfolio
- 6.4.5 CDI Labs Recent Developments
- 6.5 Biognosys
- 6.5.1 Biognosys Company Information
- 6.5.2 Biognosys Business Overview
- 6.5.3 Biognosys Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Biognosys Blood Proteomics Services Product Portfolio
- 6.5.5 Biognosys Recent Developments
- 6.6 Discovery Life Sciences
- 6.6.1 Discovery Life Sciences Company Information
- 6.6.2 Discovery Life Sciences Business Overview
- 6.6.3 Discovery Life Sciences Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Discovery Life Sciences Blood Proteomics Services Product Portfolio
- 6.6.5 Discovery Life Sciences Recent Developments
- 6.7 Firalis Molecular Precision
- 6.7.1 Firalis Molecular Precision Company Information
- 6.7.2 Firalis Molecular Precision Business Overview
- 6.7.3 Firalis Molecular Precision Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Firalis Molecular Precision Blood Proteomics Services Product Portfolio
- 6.7.5 Firalis Molecular Precision Recent Developments
- 6.8 Cell Signaling Technology (CST)
- 6.8.1 Cell Signaling Technology (CST) Company Information
- 6.8.2 Cell Signaling Technology (CST) Business Overview
- 6.8.3 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio
- 6.8.5 Cell Signaling Technology (CST) Recent Developments
- 6.9 Sampled (Infinity Biologix)
- 6.9.1 Sampled (Infinity Biologix) Company Information
- 6.9.2 Sampled (Infinity Biologix) Business Overview
- 6.9.3 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio
- 6.9.5 Sampled (Infinity Biologix) Recent Developments
- 6.10 APTBIO
- 6.10.1 APTBIO Company Information
- 6.10.2 APTBIO Business Overview
- 6.10.3 APTBIO Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 APTBIO Blood Proteomics Services Product Portfolio
- 6.10.5 APTBIO Recent Developments
- 6.11 Sinotech Genomics
- 6.11.1 Sinotech Genomics Company Information
- 6.11.2 Sinotech Genomics Business Overview
- 6.11.3 Sinotech Genomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sinotech Genomics Blood Proteomics Services Product Portfolio
- 6.11.5 Sinotech Genomics Recent Developments
- 6.12 Biodesix
- 6.12.1 Biodesix Company Information
- 6.12.2 Biodesix Business Overview
- 6.12.3 Biodesix Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Biodesix Blood Proteomics Services Product Portfolio
- 6.12.5 Biodesix Recent Developments
- 6.13 Panome Bio
- 6.13.1 Panome Bio Company Information
- 6.13.2 Panome Bio Business Overview
- 6.13.3 Panome Bio Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Panome Bio Blood Proteomics Services Product Portfolio
- 6.13.5 Panome Bio Recent Developments
- 6.14 Novogene
- 6.14.1 Novogene Company Information
- 6.14.2 Novogene Business Overview
- 6.14.3 Novogene Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Novogene Blood Proteomics Services Product Portfolio
- 6.14.5 Novogene Recent Developments
- 6.15 PTM BIO
- 6.15.1 PTM BIO Company Information
- 6.15.2 PTM BIO Business Overview
- 6.15.3 PTM BIO Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 PTM BIO Blood Proteomics Services Product Portfolio
- 6.15.5 PTM BIO Recent Developments
- 6.16 BGI Genomics
- 6.16.1 BGI Genomics Company Information
- 6.16.2 BGI Genomics Business Overview
- 6.16.3 BGI Genomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BGI Genomics Blood Proteomics Services Product Portfolio
- 6.16.5 BGI Genomics Recent Developments
- 6.17 Evotec
- 6.17.1 Evotec Company Information
- 6.17.2 Evotec Business Overview
- 6.17.3 Evotec Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Evotec Blood Proteomics Services Product Portfolio
- 6.17.5 Evotec Recent Developments
- 6.18 Metware Biotechnology
- 6.18.1 Metware Biotechnology Company Information
- 6.18.2 Metware Biotechnology Business Overview
- 6.18.3 Metware Biotechnology Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Metware Biotechnology Blood Proteomics Services Product Portfolio
- 6.18.5 Metware Biotechnology Recent Developments
- 6.19 MRM Proteomics
- 6.19.1 MRM Proteomics Company Information
- 6.19.2 MRM Proteomics Business Overview
- 6.19.3 MRM Proteomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 MRM Proteomics Blood Proteomics Services Product Portfolio
- 6.19.5 MRM Proteomics Recent Developments
- 6.20 Lc-Bio Technologies
- 6.20.1 Lc-Bio Technologies Company Information
- 6.20.2 Lc-Bio Technologies Business Overview
- 6.20.3 Lc-Bio Technologies Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Lc-Bio Technologies Blood Proteomics Services Product Portfolio
- 6.20.5 Lc-Bio Technologies Recent Developments
- 6.21 Eurofins Scientific
- 6.21.1 Eurofins Scientific Company Information
- 6.21.2 Eurofins Scientific Business Overview
- 6.21.3 Eurofins Scientific Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Eurofins Scientific Blood Proteomics Services Product Portfolio
- 6.21.5 Eurofins Scientific Recent Developments
- 6.22 MtoZ-Biolabs
- 6.22.1 MtoZ-Biolabs Company Information
- 6.22.2 MtoZ-Biolabs Business Overview
- 6.22.3 MtoZ-Biolabs Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 MtoZ-Biolabs Blood Proteomics Services Product Portfolio
- 6.22.5 MtoZ-Biolabs Recent Developments
- 6.23 Creative Proteomics
- 6.23.1 Creative Proteomics Company Information
- 6.23.2 Creative Proteomics Business Overview
- 6.23.3 Creative Proteomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Creative Proteomics Blood Proteomics Services Product Portfolio
- 6.23.5 Creative Proteomics Recent Developments
- 6.24 Macrogen
- 6.24.1 Macrogen Company Information
- 6.24.2 Macrogen Business Overview
- 6.24.3 Macrogen Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Macrogen Blood Proteomics Services Product Portfolio
- 6.24.5 Macrogen Recent Developments
- 6.25 TATAA Biocenter
- 6.25.1 TATAA Biocenter Company Information
- 6.25.2 TATAA Biocenter Business Overview
- 6.25.3 TATAA Biocenter Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 TATAA Biocenter Blood Proteomics Services Product Portfolio
- 6.25.5 TATAA Biocenter Recent Developments
- 6.26 OmicScouts (Momentum Biotechnologies)
- 6.26.1 OmicScouts (Momentum Biotechnologies) Company Information
- 6.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 6.26.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio
- 6.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 6.27 Precision Biomarker Laboratories (PBL)
- 6.27.1 Precision Biomarker Laboratories (PBL) Company Information
- 6.27.2 Precision Biomarker Laboratories (PBL) Business Overview
- 6.27.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.27.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio
- 6.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 6.28 Shanghai OE Biotech
- 6.28.1 Shanghai OE Biotech Company Information
- 6.28.2 Shanghai OE Biotech Business Overview
- 6.28.3 Shanghai OE Biotech Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.28.4 Shanghai OE Biotech Blood Proteomics Services Product Portfolio
- 6.28.5 Shanghai OE Biotech Recent Developments
- 6.29 RxCelerate
- 6.29.1 RxCelerate Company Information
- 6.29.2 RxCelerate Business Overview
- 6.29.3 RxCelerate Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.29.4 RxCelerate Blood Proteomics Services Product Portfolio
- 6.29.5 RxCelerate Recent Developments
- 6.30 Proteomics International
- 6.30.1 Proteomics International Company Information
- 6.30.2 Proteomics International Business Overview
- 6.30.3 Proteomics International Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.30.4 Proteomics International Blood Proteomics Services Product Portfolio
- 6.30.5 Proteomics International Recent Developments
- 6.31 Proteome Sciences
- 6.31.1 Proteome Sciences Company Information
- 6.31.2 Proteome Sciences Business Overview
- 6.31.3 Proteome Sciences Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.31.4 Proteome Sciences Blood Proteomics Services Product Portfolio
- 6.31.5 Proteome Sciences Recent Developments
- 6.32 Westlake Omics
- 6.32.1 Westlake Omics Company Information
- 6.32.2 Westlake Omics Business Overview
- 6.32.3 Westlake Omics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.32.4 Westlake Omics Blood Proteomics Services Product Portfolio
- 6.32.5 Westlake Omics Recent Developments
- 6.33 Crown Bioscience
- 6.33.1 Crown Bioscience Company Information
- 6.33.2 Crown Bioscience Business Overview
- 6.33.3 Crown Bioscience Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.33.4 Crown Bioscience Blood Proteomics Services Product Portfolio
- 6.33.5 Crown Bioscience Recent Developments
- 6.34 VProteomics
- 6.34.1 VProteomics Company Information
- 6.34.2 VProteomics Business Overview
- 6.34.3 VProteomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.34.4 VProteomics Blood Proteomics Services Product Portfolio
- 6.34.5 VProteomics Recent Developments
- 6.35 Shanghai Majorbio Bio-Pharm
- 6.35.1 Shanghai Majorbio Bio-Pharm Company Information
- 6.35.2 Shanghai Majorbio Bio-Pharm Business Overview
- 6.35.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.35.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio
- 6.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 6.36 Applied Biomics
- 6.36.1 Applied Biomics Company Information
- 6.36.2 Applied Biomics Business Overview
- 6.36.3 Applied Biomics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.36.4 Applied Biomics Blood Proteomics Services Product Portfolio
- 6.36.5 Applied Biomics Recent Developments
- 6.37 Sapient Bioanalytics
- 6.37.1 Sapient Bioanalytics Company Information
- 6.37.2 Sapient Bioanalytics Business Overview
- 6.37.3 Sapient Bioanalytics Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.37.4 Sapient Bioanalytics Blood Proteomics Services Product Portfolio
- 6.37.5 Sapient Bioanalytics Recent Developments
- 6.38 Allumiqs
- 6.38.1 Allumiqs Company Information
- 6.38.2 Allumiqs Business Overview
- 6.38.3 Allumiqs Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.38.4 Allumiqs Blood Proteomics Services Product Portfolio
- 6.38.5 Allumiqs Recent Developments
- 6.39 MS Bioworks
- 6.39.1 MS Bioworks Company Information
- 6.39.2 MS Bioworks Business Overview
- 6.39.3 MS Bioworks Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.39.4 MS Bioworks Blood Proteomics Services Product Portfolio
- 6.39.5 MS Bioworks Recent Developments
- 6.40 Shanghai Bioprofile
- 6.40.1 Shanghai Bioprofile Company Information
- 6.40.2 Shanghai Bioprofile Business Overview
- 6.40.3 Shanghai Bioprofile Blood Proteomics Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.40.4 Shanghai Bioprofile Blood Proteomics Services Product Portfolio
- 6.40.5 Shanghai Bioprofile Recent Developments
- 6.41 Cosmos Wisdom
- 6.42 Olink (Thermo Fisher Scientific)
- 6.43 SomaLogic (Illumina)
- 6.44 Labcorp
7 North America
- 7.1 North America Blood Proteomics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Blood Proteomics Services Market Size by Country (2021-2026)
- 7.3 North America Blood Proteomics Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Blood Proteomics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Blood Proteomics Services Market Size by Country (2021-2026)
- 8.3 Europe Blood Proteomics Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Blood Proteomics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Blood Proteomics Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Blood Proteomics Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Blood Proteomics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Blood Proteomics Services Market Size by Country (2021-2026)
- 10.3 South America Blood Proteomics Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Blood Proteomics Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Blood Proteomics Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Blood Proteomics Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst